Rise Gold SEC Filings

Rise Gold Corp. reported unregistered sales of securities tied to compensation. The company granted 1,445,469 stock options to directors and officers at an exercise price of $0.25 per share, expiring on October 30, 2030, and issued 1,365,854 deferred share units (DSUs) under its Long‑Term Incentive Plan, relying on Section 4(a)(2) of the Securities Act.

Allocations included 530,469 options and 1,000,000 DSUs to President & CEO Joseph Mullin, and 75,000 options to CFO Mihai Draguleasa. A related press release was filed as Exhibit 99.1.

Rise Gold (RYES) President and CEO Joseph Mullin filed a Form 4 detailing equity awards and holdings. He reported 1,000,000 Deferred Share Units (DSUs) granted on 10/30/2025 at $0.00, fully vested on the grant date, subject only to approval of the Long‑Term Incentive Plan at the annual general meeting to be held on 11/19/2025. Each DSU entitles the holder to one common share upon ceasing to be an Eligible Person under the plan.

He also reported option positions held indirectly by Mount Arvon Partners LLC, including 530,469 options at $0.25 exercisable 10/30/2025 and expiring 10/30/2030, plus previously awarded options such as 2,790,000 at $0.10 expiring 05/22/2030 and additional tranches expiring in 2029–2030. Warrant positions include 80,000 at $0.45 expiring 10/24/2028 and other series expiring 2025–2028. Following the reported transactions, he directly held 701,095 common shares.

Rise Gold Corp. (RYES) reported an insider transaction on a Form 4. On 10/30/2025, a director acquired 100,000 stock options at an exercise price of $0.25, exercisable on 10/30/2025 and expiring on 10/30/2030. Following the reported transactions, the insider holds 166,666 shares of common stock directly. The filing also lists previously held derivatives, including options of 60,000 (expiring 05/22/2030), 60,000 (03/25/2030), 15,000 (05/01/2029), 47,775 (12/12/2028), 94,070 (09/22/2028), and warrants of 83,333 (11/07/2025).

Rise Gold Corp. (RYES) insider Daniel Oliver, a director and 10% owner, filed a Form 4 reporting equity awards and updated holdings. On 10/30/2025, he reported 365,854 Deferred Share Units (DSUs) at $0.00 and an option grant for 300,000 shares at an exercise price of $0.25 expiring on 10/30/2030. Prior awards listed include options of 200,000 at $0.10 (05/22/2025–05/22/2030), 60,000 at $0.10 (03/25/2025–03/25/2030), 15,000 at $0.17 (05/01/2024–05/01/2029), and 200,000 at $0.25 (12/12/2023–12/12/2028), along with multiple warrants.

Following the transactions, reported beneficial ownership shows 1,210,653 shares direct and 14,663,191 shares indirect via Myrmikan Gold Fund, LLC. The filing notes a warrant standstill agreement (as amended on 05/08/2025 and 10/24/2025) under which the holder agreed not to exercise specified warrants; it may be terminated on 61 days' written notice. The DSUs are fully vested on grant, subject to approval of the company’s Long-Term Incentive Plan at the annual meeting on 11-19-25.

Rise Gold Corp. (RYES) director Thomas I. Vehrs filed a Form 4 reporting an equity award. On 10/30/2025, he acquired 100,000 stock options with a $0.25 exercise price, exercisable 10/30/2025 and expiring 10/30/2030. Ownership is reported as Direct.

The filing also lists previously granted options outstanding in multiple tranches, including 105,000 options at $0.53 expiring 02/21/2028 and 100,000 options at $0.65 expiring 02/07/2027.

Rise Gold (RYES) reported insider activity by director Lawrence W. Lepard. On 10/30/2025, he acquired 100,000 stock options at an exercise price of $0.25, exercisable on 10/30/2025 and expiring 10/30/2030. Following the filing, he reports 977,405 common shares held directly, plus indirect holdings including 2,559,656 via EMA GARP FUND LP and 904,000 via Sea View Investments, LLC.

Rise Gold (RYES) reported an insider equity update. On 10/30/2025, the company’s Chief Financial Officer acquired 75,000 stock options at an exercise price of $0.25, exercisable on 10/30/2025 and expiring on 10/30/2030.

The filing also lists existing derivative holdings: stock options of 60,000 (exercisable 05/22/2025; expire 05/22/2030) and 60,000 (exercisable 03/25/2025; expire 03/25/2030) at $0.10, plus 60,976 warrants at $0.15 (exercisable 05/08/2025; expire 05/08/2028) held indirectly by Lazuli CPA Inc. Non‑derivative common stock beneficially owned is 121,952 shares, held indirectly by Lazuli CPA Inc.

Rise Gold Corp. (RYES) received a Schedule 13G disclosing that the Abdiel group reports beneficial ownership of 26,378,262 shares, representing 19.99% of the common stock.

The position comprises 14,791,440 common shares and 11,586,822 shares issuable upon exercise of warrants with an exercise price of $0.45 per share. A “Beneficial Ownership Blocker” limits exercises that would raise ownership above 19.99%, so an additional 3,204,618 warrant shares are excluded as not currently exercisable.

Percentage ownership is calculated using 120,370,467 shares outstanding as of October 27, 2025; this is a baseline figure, not the amount being acquired. The filing is made by Abdiel Capital Advisors, LP and affiliated entities, with certification that the securities are not held for the purpose of changing or influencing control.

Rise Gold Corp. (RYES) received an insider ownership filing noting Abdiel‑affiliated funds’ holdings. The reporting persons are marked as Director and 10% Owner.

The funds beneficially own 14,791,440 shares of common stock indirectly, held by Abdiel Investments LP (4,656,007) and Investment Group of Abdiel LP (10,135,433). They also hold warrants to purchase 14,791,440 common shares at $0.45 per share, first exercisable on 10/24/2025 and expiring on 10/24/2028.

The warrants are subject to a 19.99% Beneficial Ownership Blocker. As of this filing, warrants held by Abdiel Investments LP can be exercised for 3,647,267 shares, and those held by Investment Group of Abdiel LP can be exercised for 7,939,555 shares.